Abstract | INTRODUCTION:
Cerebral toxoplasmosis is a rare but fatal complication in hematopoietic stem cell transplant patients, which mostly is caused by reactivation of latent disease. METHODS: In this study, we report an analysis of cerebral toxoplasmosis in a series of 170 allogeneic stem cell transplant patients during a 30-month period at our institution. RESULTS: Among these allogeneic stem cell transplant patients, 5 were diagnosed with cerebral toxoplasmosis by brain magnetic resonance imaging and polymerase chain reaction of Toxoplasma gondii DNA. The incidence of cerebral toxoplasmosis was found to be 2.94%. CONCLUSION: Mortality rate is known to be very high in cerebral toxoplasmosis; therefore, it is life saving to diagnose the disease in the early stages and start treatment promptly, especially in high-endemic countries like Turkey.
|
Authors | E Hakko, H A Ozkan, K Karaman, Z Gulbas |
Journal | Transplant infectious disease : an official journal of the Transplantation Society
(Transpl Infect Dis)
Vol. 15
Issue 6
Pg. 575-80
(Dec 2013)
ISSN: 1399-3062 [Electronic] Denmark |
PMID | 24103000
(Publication Type: Journal Article)
|
Copyright | © 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. |
Chemical References |
- Anti-Bacterial Agents
- Coccidiostats
- DNA, Protozoan
- Clindamycin
- Trimethoprim, Sulfamethoxazole Drug Combination
|
Topics |
- Adult
- Anti-Bacterial Agents
(therapeutic use)
- Clindamycin
(therapeutic use)
- Coccidiostats
(therapeutic use)
- DNA, Protozoan
(isolation & purification)
- Female
- Hematopoietic Stem Cell Transplantation
(adverse effects)
- Humans
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Real-Time Polymerase Chain Reaction
- Retrospective Studies
- Toxoplasma
(genetics, isolation & purification)
- Toxoplasmosis, Cerebral
(diagnosis, drug therapy, microbiology)
- Transplantation, Homologous
- Trimethoprim, Sulfamethoxazole Drug Combination
(therapeutic use)
|